These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 2379178

  • 1. In vitro differentiation of human neuroblastoma cells caused by vasoactive intestinal peptide.
    Pence JC, Shorter NA.
    Cancer Res; 1990 Aug 15; 50(16):5177-83. PubMed ID: 2379178
    [Abstract] [Full Text] [Related]

  • 2. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
    Jiang S, Kopras E, McMichael M, Bell RH, Ulrich CD.
    Cancer Res; 1997 Apr 15; 57(8):1475-80. PubMed ID: 9108448
    [Abstract] [Full Text] [Related]

  • 3. Cross-competition between vasoactive intestinal peptide and somatostatin for binding to tumor cell membrane receptors.
    Virgolini I, Yang Q, Li S, Angelberger P, Neuhold N, Niederle B, Scheithauer W, Valent P.
    Cancer Res; 1994 Feb 01; 54(3):690-700. PubMed ID: 7905785
    [Abstract] [Full Text] [Related]

  • 4. Vasoactive intestinal peptide-induced neuritogenesis in neuroblastoma SH-SY5Y cells involves SNAP-25.
    Héraud C, Chevrier L, Meunier AC, Muller JM, Chadéneau C.
    Neuropeptides; 2008 Feb 01; 42(5-6):611-21. PubMed ID: 18617262
    [Abstract] [Full Text] [Related]

  • 5. Vasoactive intestinal peptide-induced neurite remodeling in human neuroblastoma SH-SY5Y cells implicates the Cdc42 GTPase and is independent of Ras-ERK pathway.
    Alleaume C, Eychène A, Harnois T, Bourmeyster N, Constantin B, Caigneaux E, Muller JM, Philippe M.
    Exp Cell Res; 2004 Oct 01; 299(2):511-24. PubMed ID: 15350548
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vasoactive intestinal peptide stimulation of human trabecular meshwork cell growth.
    Koh SW, Yeh TH, Morris SM, Leffler M, Higginbotham EJ, Brenneman DE, Yue BY.
    Invest Ophthalmol Vis Sci; 1997 Dec 01; 38(13):2781-9. PubMed ID: 9418731
    [Abstract] [Full Text] [Related]

  • 9. Further studies on the interaction between vasoactive intestinal peptide and neuroblastoma cell lines.
    Pence JC, Shorter NA.
    Prog Clin Biol Res; 1991 Dec 01; 366():375-81. PubMed ID: 1829837
    [No Abstract] [Full Text] [Related]

  • 10. The autocrine function of vasoactive intestinal peptide on human neuroblastoma cell growth and differentiation.
    Pence JC, Shorter NA.
    Arch Surg; 1993 May 01; 128(5):591-5. PubMed ID: 8387768
    [Abstract] [Full Text] [Related]

  • 11. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
    Lutz EM, Ronaldson E, Shaw P, Johnson MS, Holland PJ, Mitchell R.
    Mol Cell Neurosci; 2006 Feb 01; 31(2):193-209. PubMed ID: 16226889
    [Abstract] [Full Text] [Related]

  • 12. Stem cell factor suppresses apoptosis in neuroblastoma cell lines.
    Timeus F, Crescenzio N, Valle P, Pistamiglio P, Piglione M, Garelli E, Ricotti E, Rocchi P, Strippoli P, Cordero di Montezemolo L, Madon E, Ramenghi U, Basso G.
    Exp Hematol; 1997 Nov 01; 25(12):1253-60. PubMed ID: 9357969
    [Abstract] [Full Text] [Related]

  • 13. Restricted localization of functional vasoactive intestinal peptide (VIP) receptors in in vitro differentiated human colonic adenocarcinoma cells (HT29-D4).
    Fantini J, Martin JM, Luis J, Rémy L, Tirard A, Marvaldi J, Pichon J.
    Eur J Cell Biol; 1988 Aug 01; 46(3):458-65. PubMed ID: 2846304
    [Abstract] [Full Text] [Related]

  • 14. Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist.
    Zia H, Hida T, Jakowlew S, Birrer M, Gozes Y, Reubi JC, Fridkin M, Gozes I, Moody TW.
    Cancer Res; 1996 Aug 01; 56(15):3486-9. PubMed ID: 8758916
    [Abstract] [Full Text] [Related]

  • 15. The VIP-receptor system in neuroblastoma cells.
    Muller JM, Philippe M, Chevrier L, Héraud C, Alleaume C, Chadéneau C.
    Regul Pept; 2006 Nov 15; 137(1-2):34-41. PubMed ID: 16989911
    [Abstract] [Full Text] [Related]

  • 16. Vasoactive intestinal peptide (VIP) stimulates rat prostatic epithelial cell proliferation.
    Juarranz MG, Bodega G, Prieto JC, Guijarro LG.
    Prostate; 2001 Jun 01; 47(4):285-92. PubMed ID: 11398176
    [Abstract] [Full Text] [Related]

  • 17. Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro.
    Sidell N.
    J Natl Cancer Inst; 1982 Apr 01; 68(4):589-96. PubMed ID: 7040765
    [Abstract] [Full Text] [Related]

  • 18. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
    Hanada M, Krajewski S, Tanaka S, Cazals-Hatem D, Spengler BA, Ross RA, Biedler JL, Reed JC.
    Cancer Res; 1993 Oct 15; 53(20):4978-86. PubMed ID: 8402688
    [Abstract] [Full Text] [Related]

  • 19. Schwannian cell differentiation of human neuroblastoma cell lines in vitro induced by bromodeoxyuridine.
    Sugimoto T, Kato T, Sawada T, Horii Y, Kemshead JT, Hino T, Morioka H, Hosoi H.
    Cancer Res; 1988 May 01; 48(9):2531-7. PubMed ID: 2833349
    [Abstract] [Full Text] [Related]

  • 20. 38-Amino acid form of pituitary adenylate cyclase activating peptide induces process outgrowth in human neuroblastoma cells.
    Deutsch PJ, Schadlow VC, Barzilai N.
    J Neurosci Res; 1993 Jun 15; 35(3):312-20. PubMed ID: 8102409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.